OU Health Sciences Center Diabetic Retinopathy Research Commercialized to Work Toward New Treatment
May 09, 2020
May 09, 2020
OKLAHOMA CITY, Oklahoma, May 9 -- The University of Oklahoma's College of Medicine issued the following news:
In people with diabetes, diabetic retinopathy is a frequent complication and the most common cause of vision loss. To curtail the prevalence of the devastating eye disease, University of Oklahoma researchers on both the Oklahoma City and Norman campuses have launched a pharmaceutical company to develop a new treatment.
The company Excitant Therapeutics was forme . . .
In people with diabetes, diabetic retinopathy is a frequent complication and the most common cause of vision loss. To curtail the prevalence of the devastating eye disease, University of Oklahoma researchers on both the Oklahoma City and Norman campuses have launched a pharmaceutical company to develop a new treatment.
The company Excitant Therapeutics was forme . . .